News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Pharm Country
ZIOPHARM Oncology, Inc. to Present at Upcoming Investor Conferences
February 21, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK, Feb. 21, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced today that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer of ZIOPHARM, will present at the following investor conferences:
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
gene therapy
Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity
January 28, 2026
·
4 min read
·
Heather McKenzie
FDA
JPM26: Beam, Cabaletta, More Zero In on Regulatory Alignment After Tumultuous Year
January 19, 2026
·
6 min read
·
Heather McKenzie
Business
JPM26 Day 2: Companies Lay Out Near-Term Revenue, Longer-Term Business Goals
January 14, 2026
·
4 min read
·
Tristan Manalac
obesity
JPM26: Novartis Doesn’t Have a GLP-1. They Don’t Miss It In a World Of Me-Toos
January 13, 2026
·
3 min read
·
Annalee Armstrong